The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers

Memantine is a noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist utilized as a palliative cure for Alzheimer’s disease. This is the second study examining the memantine concentrations in cerebrospinal fluid. The previously published study enrolled six patients, and three of them were th...

Descripción completa

Detalles Bibliográficos
Autores principales: Valis, Martin, Herman, David, Vanova, Nela, Masopust, Jiri, Vysata, Oldrich, Hort, Jakub, Pavelek, Zbysek, Klimova, Blanka, Kuca, Kamil, Misik, Jan, Zdarova Karasova, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722429/
https://www.ncbi.nlm.nih.gov/pubmed/31555132
http://dx.doi.org/10.3389/fphar.2019.00943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722429/
https://www.ncbi.nlm.nih.gov/pubmed/31555132
http://dx.doi.org/10.3389/fphar.2019.00943

Ejemplares similares